Clinical Trials Browser

Etoposide × Gynecologic × 30 days × Clear all

NCT02867956 2026-03-10

Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer

Phase 2 Completed

Ovarian Neoplasms